Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqGS - Nasdaq Real Time Price USD

Surgery Partners, Inc. (SGRY)

Compare
23.95
-0.17
(-0.70%)
At close: March 28 at 4:00:00 PM EDT
23.95
0.00
(0.00%)
After hours: March 28 at 4:05:07 PM EDT
Loading Chart for SGRY
  • Previous Close 24.12
  • Open 24.18
  • Bid 17.37 x 100
  • Ask 30.59 x 200
  • Day's Range 23.81 - 24.31
  • 52 Week Range 19.50 - 33.97
  • Volume 604,842
  • Avg. Volume 1,300,271
  • Market Cap (intraday) 3.056B
  • Beta (5Y Monthly) 2.73
  • PE Ratio (TTM) --
  • EPS (TTM) -1.33
  • Earnings Date May 5, 2025 - May 9, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 31.91

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; and ancillary services, such as multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

www.surgerypartners.com

15,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SGRY

View More

Performance Overview: SGRY

Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

SGRY
13.13%
S&P 500 (^GSPC)
5.11%

1-Year Return

SGRY
19.71%
S&P 500 (^GSPC)
6.22%

3-Year Return

SGRY
55.57%
S&P 500 (^GSPC)
21.97%

5-Year Return

SGRY
261.78%
S&P 500 (^GSPC)
119.59%

Compare To: SGRY

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SGRY

View More

Valuation Measures

Annual
As of 3/28/2025
  • Market Cap

    3.06B

  • Enterprise Value

    6.49B

  • Trailing P/E

    --

  • Forward P/E

    28.33

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.97

  • Price/Book (mrq)

    1.71

  • Enterprise Value/Revenue

    2.08

  • Enterprise Value/EBITDA

    12.94

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -5.40%

  • Return on Assets (ttm)

    4.01%

  • Return on Equity (ttm)

    0.36%

  • Revenue (ttm)

    3.11B

  • Net Income Avi to Common (ttm)

    -168.1M

  • Diluted EPS (ttm)

    -1.33

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    269.5M

  • Total Debt/Equity (mrq)

    102.14%

  • Levered Free Cash Flow (ttm)

    181.48M

Research Analysis: SGRY

View More

Company Insights: SGRY

Research Reports: SGRY

View More

People Also Watch